SE7709071L - Olivansyraestrar - Google Patents
OlivansyraestrarInfo
- Publication number
- SE7709071L SE7709071L SE7709071A SE7709071A SE7709071L SE 7709071 L SE7709071 L SE 7709071L SE 7709071 A SE7709071 A SE 7709071A SE 7709071 A SE7709071 A SE 7709071A SE 7709071 L SE7709071 L SE 7709071L
- Authority
- SE
- Sweden
- Prior art keywords
- acid esters
- olivanic acid
- gram
- olivanic
- penicillins
- Prior art date
Links
- HFTVKHFILHLXJF-NSCUHMNNSA-N 3-[(e)-2-aminoethenyl]sulfanyl-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical class C1C(S\C=C\N)=C(C(O)=O)N2C(=O)C(C(O)C)C21 HFTVKHFILHLXJF-NSCUHMNNSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 108020004256 Beta-lactamase Proteins 0.000 abstract 1
- 229930186147 Cephalosporin Natural products 0.000 abstract 1
- 229930182555 Penicillin Natural products 0.000 abstract 1
- 102000006635 beta-lactamase Human genes 0.000 abstract 1
- 229940124587 cephalosporin Drugs 0.000 abstract 1
- 150000001780 cephalosporins Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002960 penicillins Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5456—Arylalkanephosphonium compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB34106/76A GB1531141A (en) | 1976-08-17 | 1976-08-17 | Beta-lactam antibiotics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7709071A0 SE7709071A0 (sv) | 1978-02-17 |
| SE7709071L true SE7709071L (sv) | 1978-02-17 |
Family
ID=10361448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7709071A SE7709071L (sv) | 1976-08-17 | 1977-08-10 | Olivansyraestrar |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5323995A (sv) |
| AT (1) | AT351678B (sv) |
| AU (1) | AU518375B2 (sv) |
| BE (1) | BE857781A (sv) |
| CA (1) | CA1104139A (sv) |
| CH (1) | CH639664A5 (sv) |
| DE (1) | DE2736482A1 (sv) |
| DK (1) | DK364177A (sv) |
| ES (1) | ES461691A1 (sv) |
| FI (1) | FI772432A7 (sv) |
| FR (2) | FR2362142A1 (sv) |
| GB (1) | GB1531141A (sv) |
| IE (1) | IE45559B1 (sv) |
| IL (1) | IL52638A (sv) |
| NL (1) | NL7709007A (sv) |
| NZ (1) | NZ184808A (sv) |
| PT (1) | PT66882B (sv) |
| SE (1) | SE7709071L (sv) |
| ZA (1) | ZA774703B (sv) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2862419D1 (en) * | 1977-11-12 | 1984-07-26 | Beecham Group Plc | Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates |
| EP0004132A1 (en) * | 1978-03-04 | 1979-09-19 | Beecham Group Plc | Esters of beta-lactam antibiotics, a process for their preparation pharmaceutical compositions containing them and the compounds for use as antibacterial agents |
| US4446146A (en) * | 1978-07-26 | 1984-05-01 | Beecham Group Limited | β-Lactam containing compounds, their preparation and use |
| DE2963580D1 (en) * | 1978-08-02 | 1982-10-21 | Beecham Group Plc | Beta-lactam antibacterial agents, a process for their preparation and pharmaceutical compositions containing them |
| US4530791A (en) * | 1979-04-16 | 1985-07-23 | Kowa Co., Ltd. | β-Lactam antibiotics |
| DE3070269D1 (en) * | 1979-08-10 | 1985-04-18 | Beecham Group Plc | Beta-lactam antibiotics, their preparation, pharmaceutical compositions containing them and their preparation |
| EP0044142A1 (en) * | 1980-07-03 | 1982-01-20 | Beecham Group Plc | Process for the preparation of beta-lactam antibiotics |
| EP0057565A1 (en) * | 1981-02-04 | 1982-08-11 | Beecham Group Plc | Beta-lactam antibiotics, their preparation and use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH633554A5 (en) * | 1975-11-21 | 1982-12-15 | Merck & Co Inc | Process for the preparation of novel thienamycin derivatives. |
-
1976
- 1976-08-17 GB GB34106/76A patent/GB1531141A/en not_active Expired
-
1977
- 1977-08-02 IL IL52638A patent/IL52638A/xx unknown
- 1977-08-02 NZ NZ184808A patent/NZ184808A/xx unknown
- 1977-08-03 PT PT66882A patent/PT66882B/pt unknown
- 1977-08-04 ZA ZA00774703A patent/ZA774703B/xx unknown
- 1977-08-10 SE SE7709071A patent/SE7709071L/sv not_active Application Discontinuation
- 1977-08-12 FR FR7724894A patent/FR2362142A1/fr active Granted
- 1977-08-12 DE DE19772736482 patent/DE2736482A1/de not_active Withdrawn
- 1977-08-12 BE BE180166A patent/BE857781A/xx not_active IP Right Cessation
- 1977-08-12 FI FI772432A patent/FI772432A7/fi not_active Application Discontinuation
- 1977-08-15 CH CH996577A patent/CH639664A5/de not_active IP Right Cessation
- 1977-08-16 AT AT592177A patent/AT351678B/de not_active IP Right Cessation
- 1977-08-16 CA CA284,777A patent/CA1104139A/en not_active Expired
- 1977-08-16 IE IE1713/77A patent/IE45559B1/en unknown
- 1977-08-16 DK DK364177A patent/DK364177A/da not_active Application Discontinuation
- 1977-08-16 NL NL7709007A patent/NL7709007A/xx not_active Application Discontinuation
- 1977-08-17 AU AU27986/77A patent/AU518375B2/en not_active Expired
- 1977-08-17 ES ES461691A patent/ES461691A1/es not_active Expired
- 1977-08-17 JP JP9909877A patent/JPS5323995A/ja active Pending
-
1978
- 1978-11-10 FR FR7831817A patent/FR2405260A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| IL52638A (en) | 1980-12-31 |
| IE45559L (en) | 1978-02-17 |
| AU2798677A (en) | 1979-02-22 |
| AU518375B2 (en) | 1981-10-01 |
| DE2736482A1 (de) | 1978-02-23 |
| SE7709071A0 (sv) | 1978-02-17 |
| PT66882A (fr) | 1977-09-01 |
| CA1104139A (en) | 1981-06-30 |
| FR2405260B1 (sv) | 1980-10-31 |
| NL7709007A (nl) | 1978-02-21 |
| AT351678B (de) | 1979-08-10 |
| BE857781A (fr) | 1978-02-13 |
| ES461691A1 (es) | 1978-06-01 |
| FR2362142A1 (fr) | 1978-03-17 |
| FI772432A7 (fi) | 1978-02-18 |
| PT66882B (fr) | 1979-01-24 |
| DK364177A (da) | 1978-02-18 |
| CH639664A5 (en) | 1983-11-30 |
| JPS5323995A (en) | 1978-03-06 |
| FR2362142B1 (sv) | 1981-11-06 |
| ATA592177A (de) | 1979-01-15 |
| ZA774703B (en) | 1978-06-28 |
| NZ184808A (en) | 1980-04-28 |
| IE45559B1 (en) | 1982-09-22 |
| FR2405260A1 (fr) | 1979-05-04 |
| IL52638A0 (en) | 1977-10-31 |
| GB1531141A (en) | 1978-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8305916D0 (sv) | Mellanprodukter for framstellning av penicillansyra-1,1-dioxider | |
| ES480915A1 (es) | Un procedimiento para la preparacion de antibioticos de ce- falosporinas. | |
| ES459785A1 (es) | Un procedimiento para la preparacion de nuevos esteres anti-bacterianos. | |
| SE7611047L (sv) | Forfarande for framstellning av antibakteriella emnen | |
| IE782546L (en) | Amino-thiazolyl cephalosporins | |
| SE7709071L (sv) | Olivansyraestrar | |
| SE7706081L (sv) | Forfarande for framstellning av cefalosporiner | |
| ES455404A1 (es) | Un procedimiento para la preparacion de nuevos derivados de beta-lactama. | |
| SE8104771L (sv) | Cefalosporinderivat | |
| FR2191556A5 (en) | N-Acylampicillins - with broad-spectrum antibacterial activity prepd. by acylation with naphthyridine carboxylic acids | |
| SE7909501L (sv) | Cefalosporin-antibiotika | |
| FR2355848A1 (fr) | 7-(a-(2,3-dihydro-2-oxobenzimidazol-1-yl-carbonylamino) arylacetamido) cephalosporines | |
| SE7600397L (sv) | Forfarande for framstellning av penicilliner | |
| SE7712645L (sv) | Monocykliska beta-laktamer med antibakteriell aktivitet | |
| GB1547473A (en) | Cephalosporin compounds | |
| ES438853A1 (es) | Un procedimiento de preparacion de nuevos esteres de acidos cefalosporinicos. | |
| SE8008540L (sv) | N-substituerade tiazolylderivat av oxi-imino-substituerade cefalosporiner och forfarande for framstellning derav | |
| SE7713710L (sv) | Framstellning av nya etrar | |
| FR2361403A1 (fr) | 7-12-(2-imino-3-hydroxy-4-thiazolin-4-ml)-acetamido) antibiotiques | |
| ES423024A1 (es) | Procedimiento para la preparacion de derivados de acidos penicilanico y cefalosporanico. | |
| FI54495B (fi) | Foerfarande foer framstaellning av ett gentemot gram-positiva bakterier aktivt polypeptid-antibiotikum benaemnd gardimycin | |
| SE8303727L (sv) | Cefalosporinantibiotika | |
| GB1539053A (en) | Process for the preparation of alpha-(2-oxoimidazolidinyl carbonylamino)-acetamido cephalosporins | |
| ES454009A1 (es) | Un procedimiento para la preparacion de nuevos esteres de derivados del acido clavulanico. | |
| ES476259A1 (es) | Un procedimiento para la preparacion de un compuesto. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 7709071-0 |